Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Peritoneal Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00398138
What this trial is testing

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

Who this might be right for
LeukemiaLung CancerMalignant Mesothelioma+2 more
Memorial Sloan Kettering Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT02040142
What this trial is testing

HIPEC for Peritoneal Carcinomatosis

Who this might be right for
Peritoneal CarcinomatosisColorectal CancerAppendiceal Cancer+3 more
Albert Einstein College of Medicine 51
Not applicableStudy completedNCT00897442
What this trial is testing

Collecting Tumor Samples From Patients With Gynecological Tumors

Who this might be right for
Borderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more
Gynecologic Oncology Group 275
Testing effectiveness (Phase 2)Looking for participantsNCT06057935
What this trial is testing

Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

Who this might be right for
Malignant Peritoneal MesotheliomaPeritoneal MesotheliomaMesothelioma+2 more
Memorial Sloan Kettering Cancer Center 64
Testing effectiveness (Phase 2)Study completedNCT01592383
What this trial is testing

Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma

Who this might be right for
Malignant Peritoneal Mesothelioma
University of Chicago 2
Testing effectiveness (Phase 2)Study completedNCT02399371
What this trial is testing

Pembrolizumab in Treating Patients With Malignant Mesothelioma

Who this might be right for
Biphasic MesotheliomaEpithelioid MesotheliomaPeritoneal Malignant Mesothelioma+7 more
University of Chicago 65
Early research (Phase 1)Study completedNCT00402766
What this trial is testing

Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma

Who this might be right for
Mesothelioma
M.D. Anderson Cancer Center 19
Early research (Phase 1)Looking for participantsNCT04847063
What this trial is testing

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

Who this might be right for
Peritoneal MesotheliomaPeritoneal CarcinomatosisOvarian Cancer+4 more
National Cancer Institute (NCI) 60
Very early researchEnded earlyNCT04213794
What this trial is testing

Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients

Who this might be right for
Malignant Abdominal NeoplasmMalignant Pelvic NeoplasmRecurrent Colon Carcinoma+24 more
Mayo Clinic 2
Testing effectiveness (Phase 2)UnknownNCT04462809
What this trial is testing

Efficacy of a Maintenance Treatment With TALAzoparib Following First Line Platinum-based Chemotherapy in Malignant MESOthelioma

Who this might be right for
Advanced Malignant Pleural or Peritoneal Mesothelioma
Hospices Civils de Lyon 40
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Looking for participantsNCT07510815
What this trial is testing

Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma

Who this might be right for
Malignant Pleural Mesotheliomas
Beijing Biotech 36
Testing effectiveness (Phase 2)Study completedNCT00061477
What this trial is testing

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma

Who this might be right for
Mesothelioma
Eli Lilly and Company 48
Early research (Phase 1)Looking for participantsNCT07277413
What this trial is testing

IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Who this might be right for
NSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+10 more
IDEAYA Biosciences 260
Early research (Phase 1)Ended earlyNCT03436732
What this trial is testing

Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma

Who this might be right for
Mesothelioma
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)UnknownNCT02588131
What this trial is testing

Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)

Who this might be right for
Pleural MesotheliomaPeritoneal Mesothelioma
Italian Network for Tumor Biotherapy Foundation 40
Early research (Phase 1)Study completedNCT03507452
What this trial is testing

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

Who this might be right for
Advanced Recurrent Malignant Pleural Epithelioid MesotheliomaAdvanced Recurrent Malignant Peritoneal Epithelioid MesotheliomaAdvanced Recurrent Serous Ovarian Cancer+1 more
Bayer 36
Not applicableUnknownNCT03210298
What this trial is testing

International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

Who this might be right for
Peritoneum CancerPeritoneum NeoplasmPleural Cancer+12 more
Sabine Rhode 1,000
Not applicableLooking for participantsNCT01416714
What this trial is testing

Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy

Who this might be right for
Gastric Cancers
University of Chicago 1,000
Testing effectiveness (Phase 2)Ended earlyNCT05451849
What this trial is testing

A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

Who this might be right for
MesotheliomaMesotheliomas PleuralMesothelioma, Malignant+14 more
TCR2 Therapeutics 14
Next Page